Physician profile
Juan C Goez
NPI 1770515488
$12,763.29
in general payments reported to CMS, 2019-2025
31 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what 88% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,588 · 2020: $1,802 · 2021: $1,508 · 2022: $664 · 2023: $3,066 · 2024: $1,962 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,590 · Travel and Lodging: $1,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,590.25 |
| Travel and Lodging | $1,611.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,674.84 | 2019-2024 | Versajet, Grafix Pl, Stravix Pl |
| Integra Lifesciences Corporation | $2,181.71 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $1,359.57 | 2019-2022 | |
| Wright Medical Technology, INC. | $1,164.77 | 2019-2020 | |
| Biopro, INC. | $769.52 | 2023-2025 | Hemi-Toe |
| Stryker Corporation | $621.08 | 2021-2025 | Citrefix, Augment Injectable, Flexband |
| Arthrex, INC. | $471.35 | 2024 | |
| Djo, LLC | $469.65 | 2019-2025 | Cmf |
| Nevro Corp. | $326.03 | 2022-2024 | Senza |
| Kerecis Limited | $295.18 | 2019-2022 | |
| Davol INC. | $234.27 | 2024-2025 | Arista Ah Flexitip, Arista |
| Abbvie INC. | $231.64 | 2021-2025 | |
| Averitas Pharma INC. | $228.65 | 2023-2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $204.45 | 2022-2024 | Nuzyra |
| Allergan, INC. | $192.86 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $185.06 | 2023 | Seglentis |
| Globus Medical, INC. | $184.12 | 2025 | Senza |
| Treace Medical Concepts, INC. | $170.03 | 2024-2025 | |
| Polaris Technology Solutions LLC | $151.58 | 2024 | |
| Sandoz INC. | $132.29 | 2019-2020 | |
| Acera Surgical, INC. | $130.18 | 2024 | Restrata Wound Matrix |
| Orthofix Medical, INC. | $91.38 | 2019-2025 | Physio-Stim |
| Bioventus LLC | $87.04 | 2021-2023 | |
| Access Pro Medical, LLC | $82.75 | 2025 | Matriderm |
| Merck Sharp & Dohme LLC | $27.11 | 2019 | |
| Linvatec Corporation | $23.83 | 2023 | Biobrace 23mm |
| Aroa Biosurgery Incorporated | $19.01 | 2020 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Paragon 28, INC. | $13.90 | 2019 | |
| Abbott Laboratories | $13.86 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Goez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.